Table 3.
Model #2 (eosinophil percentage) of multivariate logistic regression of variables associated with clinically significant improvement (>9) in SNOT-22 score.
| Variable | 95% Confidence Interval | Odds Ratio | p Value |
|---|---|---|---|
| Age | −0.13–0.02 | 0.94 | 0.09 |
| Gender | −0.42–1.97 | 2.16 | 0.1 |
| Samter’s triad | −1.07–0.98 | 0.95 | 0.87 |
| Asthma | −2.68–5.42 | 3.93 | 0.28 |
| Antihistamine/Montelukast usage | −1.28–0.99 | 0.86 | 0.64 |
| Steroid nasal spray usage | −0.46–1.71 | 1.86 | 0.13 |
| Steroid inhaler usage | −1.75–1.72 | 0.98 | 0.97 |
| Blood Eosinophils% | −0.01–0.09 | 1.04 | 0.09 |
| Number of prior endoscopic sinus surgeries | −0.55–0.77 | 1.11 | 0.55 |